UK Influenza Diagnostics Market Size & Outlook, 2023-2030

The influenza diagnostics market in UK is expected to reach a projected revenue of US$ 162.1 million by 2030. A compound annual growth rate of 7% is expected of UK influenza diagnostics market from 2024 to 2030.
Revenue, 2023 (US$M)
$100.9
Forecast, 2030 (US$M)
$162.1
CAGR, 2024 - 2030
7%
Report Coverage
UK

UK influenza diagnostics market highlights

  • The UK influenza diagnostics market generated a revenue of USD 100.9 million in 2023 and is expected to reach USD 162.1 million by 2030.
  • The UK market is expected to grow at a CAGR of 7% from 2024 to 2030.
  • In terms of segment, ridt was the largest revenue generating test type in 2023.
  • RIDT is the most lucrative test type segment registering the fastest growth during the forecast period.

Influenza diagnostics market data book summary

Market revenue in 2023USD 100.9 million
Market revenue in 2030USD 162.1 million
Growth rate7% (CAGR from 2023 to 2030)
Largest segmentRidt
Fastest growing segmentRIDT
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationRIDT, RT-PCR, Cell Culture
Key market players worldwide3M Co, Abbott Laboratories, Becton Dickinson & Co, Meridian Bioscience, QuidelOrtho Corp, Roche Holding AG, Sekisui Chemical Co Ltd, Thermo Fisher Scientific Inc, Hologic Inc, SA Scientific

Other key industry trends

  • In terms of revenue, UK accounted for 6.2% of the global influenza diagnostics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany influenza diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 162.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Influenza Diagnostics Market Companies

Name Profile # Employees HQ Website

UK influenza diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to influenza diagnostics market will help companies and investors design strategic landscapes.


Ridt was the largest segment with a revenue share of 30.92% in 2023. Horizon Databook has segmented the UK influenza diagnostics market based on ridt, rt-pcr, cell culture covering the revenue growth of each sub-segment from 2018 to 2030.


  • UK Influenza Diagnostics Test Type Outlook (Revenue, USD Million, 2018-2030)
    • RIDT
    • RT-PCR
    • Cell Culture
    • Others
  • UK Influenza Diagnostics End Use Outlook (Revenue, USD Million, 2018-2030)
    • Hospitals
    • POCT
    • Laboratories

Reasons to subscribe to UK influenza diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UK influenza diagnostics market databook

  • Our clientele includes a mix of influenza diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UK influenza diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into UK influenza diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UK influenza diagnostics market size, by test type, 2018-2030 (US$M)

UK Influenza Diagnostics Market Outlook Share, 2023 & 2030 (US$M)

UK influenza diagnostics market size, by test type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more